Collagenase Total Occlusion-1 Trial.

Trial Profile

Collagenase Total Occlusion-1 Trial.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Mar 2016

At a glance

  • Drugs Collagenase (Primary)
  • Indications Coronary artery disease
  • Focus Adverse reactions
  • Acronyms CTO-1
  • Most Recent Events

    • 08 Mar 2016 Results (n = 20) published in the Circulation.
    • 22 Mar 2012 Actual end date (February 2012) added as reported by ClinicalTrials.gov.
    • 22 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top